article thumbnail

Could NfL accelerate drug development for neurodegenerative diseases?

Drug Discovery World

Professor Andy Whiting and Dr Tony Lockett discuss how specific levels of a protein could be used to advance drug development in neurodegenerative diseases. The post Could NfL accelerate drug development for neurodegenerative diseases? appeared first on Drug Discovery World (DDW).

article thumbnail

Women in STEM with Dr Petra Dieterich

Drug Target Review

I went back to school in 2016 to study for an MBA at Imperial College in London, this time finding a much more diverse cultural environment. About the author Dr Petra Dieterich, Senior Vice President at Abzena Petra has 30 years experience of in drug development in the pharmaceutical industry with a focus on supporting CMC activities.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Antibody Drug Conjugates: windows of opportunity

Drug Target Review

The authors also explore the need for further data to improve understanding and refine drug design with safety and efficacy in mind. Antibody drug conjugated with cytotoxic payload. antibody linked to a biologically active cytotoxic (anticancer) payload or drug 3d rendering. Cancer Cell [Internet].

article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

After graduating, Miles went on to work as a scientist on AstraZeneca’s Research and Development graduate programme, working on projects in biocatalysis, computational organic chemistry and machine learning for drug discovery.